BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1014043)

  • 21. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexistence of cytoplasmic and nuclear estrogen receptors. A histochemical study on human mammary cancer and rabbit uterus.
    Lee SH
    Cancer; 1989 Oct; 64(7):1461-6. PubMed ID: 2550122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of post-synthetic modifications of proteins on the binding of estrogen-receptor complex to uterine nuclei of aging rats.
    Kaur J; Thakur MK
    Mol Biol Rep; 1990 Nov; 14(4):261-4. PubMed ID: 2094802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the nuclear localization of [3H]estradiol in rat uterine tissue in vitro.
    Campbell PS; Albright CW; Wilson JH; Bridges RR
    J Steroid Biochem; 1989 May; 32(5):681-7. PubMed ID: 2739408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced inhibition of estrogen receptor nuclear binding in the uterus of aged mice.
    Belisle S; Bellabarba D; Lehoux JG
    J Steroid Biochem; 1987 May; 26(5):521-6. PubMed ID: 3586669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone binding of estradiol-17 beta receptor: evidence for its regulation by cytoplasmic phosphorylation and nuclear dephosphorylation. Prevention of dephosphorylation by antiestrogens.
    Migliaccio A; Auricchio F
    J Steroid Biochem; 1981 Dec; 15():369-73. PubMed ID: 6279967
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of steroid-binding sites by affinity labeling. Further studies of the interaction between 4-mercuri-17-beta-estradiol and specific estrogen-binding proteins in the rat uterus.
    Muldoon TG
    Biochemistry; 1971 Sep; 10(20):3780-4. PubMed ID: 5096399
    [No Abstract]   [Full Text] [Related]  

  • 30. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.
    Bayard F; Damilano S; Robel P; Baulieu EE
    J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear estrogen receptors in human uterine arteries.
    Batra S; Iosif S
    Gynecol Obstet Invest; 1987; 24(4):250-5. PubMed ID: 3428713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytoplasm to nucleus translocation patterns of different forms of hepatic estrogen receptors].
    Mataradze GD; Kondrat'ev IaIu; Gontar' EV; Smirnov AN; Rozen VB
    Biull Eksp Biol Med; 1981 May; 91(5):568-71. PubMed ID: 7260387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unbound progesterone receptors are in equilibrium between the nucleus and cytoplasm in cells of the rat uterus.
    Sheridan PJ; Buchanan JM; Anselmo VC; Martin PM
    Endocrinology; 1981 Apr; 108(4):1533-7. PubMed ID: 7193570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro.
    Williams D; Gorski J
    Biochemistry; 1974 Dec; 13(27):5537-42. PubMed ID: 4457113
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of estrogen receptors in human premenopausal and postmenopausal uteri: indication of biologically inactive receptor in postmenopausal uteri.
    Strathy JH; Coulam CB; Spelsberg TC
    Am J Obstet Gynecol; 1982 Feb; 142(4):372-82. PubMed ID: 7058843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic estrogen treatment causes an alteration in uterine estrogen receptor dynamics of rats.
    Sato B; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Biochim Biophys Acta; 1983 Feb; 755(3):412-9. PubMed ID: 6824737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association and dissociation of estrogen receptor with estrogen receptor-binding factors is regulated by Mg2+.
    Fukai F; Murayama A
    J Biochem; 1984 Apr; 95(4):1227-30. PubMed ID: 6746599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic and nuclear binding of estradiol in the brain and pituitary of old female rats.
    Jiang MJ; Peng MT
    Gerontology; 1981; 27(1-2):51-7. PubMed ID: 7215820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.